Health Condition 1: M256- Stiffness of joint, not elsewhereclassified
Conditions
Interventions
Intervention1: wh5 gel: Group A- Trial group - WH5 GEL -local application on wound followed by dressing with gauze and bandage daily once up to trial period
Control Intervention1: Povidone iodine oint
Sponsors
Gufic Biosciences Limited
National Institute of Ayurveda
Eligibility
Inclusion criteria
Inclusion criteria: Patients having sign and symptoms of Dushta Vrana
Exclusion criteria
Exclusion criteria: 1.Patients with severe complications and requiring surgery 2.Wound with other disorders like HIV ,Hepatitis B etc. 3.Malignant ulcer 4.Tuberculous ulcer 5.Syphilitic ulcer 6.Leprosy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of test drug and control drug effect on wound healingTimepoint: Active treatment-2months Follow up-2 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Assessment of patient compliance to test drug snd control drugTimepoint: Active treatment- 2 months Follow up-2 months | — |
Countries
India
Contacts
Public ContactDr Katarmal Durga Harishbhai
National Institute of Ayurveda, Jaipur
Outcome results
None listed